FindTrial
Sign In

To Assess poor prognosis in Acute leukemia ininfants and children by molecular studies

Expression of KMT2A/MLL gene translocations in paediatric Acute Lymphoblastic Leukemia by Fluorescence in situ hybridisation and its correlation with Flow cytometry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/07/026327
Enrollment
40
Registered
2020-07-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]

Interventions

None listed

Sponsors

MAULANA AZAD MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All newly diagnosed cases of paediatric Acute Lymphoblastic Leukemia.

Exclusion criteria

Exclusion criteria: All paediatric Acute Lymphoblastic Leukemia cases on treatment.

Design outcomes

Primary

MeasureTime frame
Expression of KMT2A/MLL gene translocation in paediatric Acute lymphoblastic leukemiaTimepoint: At the time of inclusion of the case—

Secondary

MeasureTime frame
Association with clinico-haematological and immunophenotypic parametersTimepoint: At the time of inclusion of the case—

Countries

India

Contacts

Public ContactSARIKA SINGH

MAULANA AZAD MEDICAL COLLEGE, NEW DELHI

sarikasingh97b@gmail.com9911182326

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026